NASDAQ: BNTC
Benitec Biopharma Inc Stock Ownership - Who owns Benitec Biopharma?

Insider buying vs selling

Have Benitec Biopharma Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Suvretta Capital Management LLCDirector2025-12-2911,587$13.44
$155.73kBuy
Suvretta Capital Management LLCDirector2025-12-2965,800$13.44
$884.35kBuy
Suvretta Capital Management LLCDirector2025-12-262,516$13.10
$32.96kBuy
Suvretta Capital Management LLCDirector2025-12-2614,320$13.10
$187.59kBuy
Suvretta Capital Management LLCDirector2025-12-2342,600$12.85
$547.41kBuy
Suvretta Capital Management LLCDirector2025-12-237,400$12.85
$95.09kBuy
Suvretta Capital Management LLCDirector2025-12-222,892$12.08
$34.94kBuy
Suvretta Capital Management LLCDirector2025-12-2216,650$12.08
$201.13kBuy
Suvretta Capital Management LLCDirector2025-12-192,434$11.48
$27.94kBuy
Suvretta Capital Management LLCDirector2025-12-1913,950$11.48
$160.15kBuy

1 of 2

BNTC insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when BNTC insiders and whales buy or sell their stock.

BNTC Shareholders

What type of owners hold Benitec Biopharma Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Suvretta Capital Management LLC6.02%2,069,267$25.00MInsider
Steven Michael Oliveira1.94%668,123$8.07MInsider
J. Kevin Buchi0.45%155,723$1.88MInsider
Megan Boston0.08%25,927$313.20kInsider
Suvret0.03%11,548$139.50kInstitution
Montanova Capital LLC0.03%11,548$139.50kInstitution
Sophie Mukadam0.02%6,016$72.67kInsider
Juptop0.01%2,479$29.95kInstitution
Jupiter Topco LLC0.01%2,478$29.93kInstitution
Frares0.01%2,413$29.15kInstitution

1 of 3

BNTC vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
BNTC0.10%8.51%Net Buying
GALT0.01%99.99%Net BuyingNet Buying
RCKT0.09%87.39%Net SellingNet Selling
FENC0.00%100.00%Net SellingNet Selling
BBOT0.07%42.55%Net SellingNet Selling

Benitec Biopharma Stock Ownership FAQ

Who owns Benitec Biopharma?

Benitec Biopharma (NASDAQ: BNTC) is owned by 0.10% institutional shareholders, 8.51% Benitec Biopharma insiders, and 91.39% retail investors. Suvretta Capital Management LLC is the largest individual Benitec Biopharma shareholder, owning 2.07M shares representing 6.02% of the company. Suvretta Capital Management LLC's Benitec Biopharma shares are currently valued at $22.87M.

If you're new to stock investing, here's how to buy Benitec Biopharma stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.